Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
Markus Müller, President (Rector) at University of Vienna, Member of the Board of Trustees at Austrian National Library, President of the Supreme Medical Council at Federal Ministry of Labour, Social Affairs, Health, Care and Consumer Protection, Chairman of the Supervisory Board at University Hospital AKH Vienna, shared a post on LinkedIn about a recent article by Scott B. Vafai et al., published in NEJM, adding:
“Fascinating article about a new base editing approach targeting PCSK9 to lower cholesterol levels in the NEJM.”
Title: In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
Authors: Scott B. Vafai, Jörg Täubel, Thomas Ashdown, Riyaz S. Patel, Sadaf Diamondali, Jaimini Cegla, Handrean Soran, Bilal Bashir, Alexander Abitbol, Daniel Gaudet, Alex Lauzière, Liam R. Brunham, David E. Newby, Stephen J. Nicholls, Russell S. Scott, Jane Kerr, Jean-Claude Tardif, Catherine Lunken, Steve E. Humphries, Verena Karsten, Patrick D. Tyler, Xinyan Zhang, Nidal Huniti, Patrick A. Flight, Chelsey L. Jensen, Rick Falzone, Joseph C. Biedenkapp, Troy Lister, Leslie E. Stolz, Amit V. Khera, Sekar Kathiresan

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments